qXR-CTR vs Aorta-CAD
AI Verdict
Choose qXR-CTR if…
Choose qXR-CTR if your primary objective is the automated, accurate measurement of the cardiothoracic ratio from chest X-rays to assess overall heart size. This tool is ideal for screening patients for potential heart failure risk and monitoring cardiac enlargement efficiently within a radiology or cardiology workflow.
View qXR-CTR →Choose Aorta-CAD if…
Choose Aorta-CAD if your clinical focus is on the early detection and highlighting of specific aortic pathologies such as Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. This solution is particularly valuable for physicians needing assistance in identifying subtle signs of aortic calcification or dilation to improve diagnostic accuracy and reduce missed findings.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | qXR-CTR | Aorta-CAD |
|---|---|---|
| Deployment | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. | Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Aorta-CADAorta-CAD emphasizes seamless integration into existing X-ray reading workflows without requiring new PACS technology or costly re-training, which significantly enhances usability for physicians. Its toggleable overlay for annotations also provides flexibility and control within the diagnostic process, contributing to a superior user experience.
Clinical Value
Aorta-CADAorta-CAD clearly demonstrates its clinical value with specific, quantifiable outcomes from a clinical study, showing a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta. Furthermore, 96% of physicians showed improvement when assisted by the device. While qXR-CTR is FDA-cleared and aids in heart failure risk assessment, it lacks similarly detailed, direct clinical outcome metrics in the provided information.
Pricing & Value
TieBoth qXR-CTR and Aorta-CAD state that pricing information is not publicly disclosed and requires direct contact with the vendor. Without any transparent pricing models or comparative cost data, it is not possible to determine which tool offers better value.
Enterprise Readiness
qXR-CTRBoth tools are HIPAA compliant, have BAA, and are FDA cleared. However, qXR-CTR offers more flexible deployment options, supporting cloud, on-premise, and hybrid environments. This versatility makes it more adaptable to diverse enterprise IT infrastructures and security requirements compared to Aorta-CAD's cloud-based-only deployment.
Innovation
qXR-CTRBoth tools leverage deep learning for chest X-ray analysis and are FDA-cleared. Qure.ai, the developer of qXR-CTR, is recognized as a 'trailblazer in AI-driven medical imaging innovation' and holds an 'industry record for the greatest number of FDA-cleared findings on CXR scans'. This broader innovative footprint and extensive portfolio of FDA-cleared algorithms suggest a more comprehensive and sustained commitment to AI innovation in radiology.
Support & Docs
Aorta-CADImagen Technologies offers comprehensive program support, including 24/7 emergency support, a single direct contact for support, and assistance with installation, EMR integration, staff training, and accreditation. While Qure.ai provides a dedicated client success partner and documented support channels with a stated response time, Imagen's holistic operational support package for enterprise clients appears more extensive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | qXR-CTR | Aorta-CAD |
|---|---|---|
| Tool Name | qXR-CTR | Aorta-CAD |
| Company | Qure.ai Technologies | Imagen Technologies |
| Primary Purpose | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. | FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows. |
| Target Conditions/Measurements | Cardiothoracic Ratio (CTR) measurement, assessment of heart size and potential heart failure risk. | Signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. |
| Specialties | Cardiology, Radiology | Cardiology, Internal Medicine, Radiology |
Videos
Demos, reviews, and walkthroughs featuring qXR-CTR and Aorta-CAD.